|
|
| Neoplasms of the CNS |
|
Free Subscription
1 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Neoplasms of the CNS is free of charge.
Identification and validation of cuproptosis-related immune checkpoint expression
for glioblastoma.
BMC Cancer. 2025;25:1723.
PubMed
Abstract available
Phenotypic stratification of Low-grade Glioma using multimodal MRI via
outcome-weighted integrative clustering.
BMC Neurol. 2025;25:452.
PubMed
Abstract available
ASTRO updates guideline on radiation therapy for grade 4 diffuse gliomas: After
maximum safe resection, radiation therapy is the primary modality of therapy for
grade 4 diffuse gliomas.
Cancer. 2025;131:e70089.
PubMed
The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of
Clinical and Genomic Data from Patients.
Cancer Res. 2025 Nov 5:OF1-OF9. doi: 10.1158/0008-5472.CAN-24-4976.
PubMed
Abstract available
An analysis of short-term outcomes and healthcare resource utilization for
ventriculoperitoneal shunt versus endoscopic third ventriculostomy in pediatric
patients with hydrocephalus following posterior fossa brain tumor resection.
Childs Nerv Syst. 2025;41:343.
PubMed
Abstract available
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or
Oligodendroglioma Following Surgery.
Clin Cancer Res. 2025;31:4412-4418.
PubMed
Abstract available
Brain tumor microenvironment: Mechanisms, interactions, and therapeutic
opportunities.
Clin Neuropathol. 2025 Nov 5. doi: 10.5414/NP301671.
PubMed
Abstract available
Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With
Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003.
J Clin Oncol. 2025 Aug 11:JCO2500221. doi: 10.1200/JCO-25-00221.
PubMed
Abstract available
The current status of immune checkpoint inhibitors in pediatric CNS tumors: a
systematic review with a representative case of CMMRD-associated glioma.
J Neurooncol. 2025;176:63.
PubMed
Abstract available
Investigation of 6-thioguanine as a strategy to overcome methotrexate resistance
in a mouse model of leptomeningeal carcinomatosis.
J Neurooncol. 2025;176:64.
PubMed
Abstract available
Peripheral neural crest tumor brain metastases management: a single-institution
retrospective study.
J Neurooncol. 2025;176:65.
PubMed
Correction to: Stereotactic radiosurgery for patients with extensive brain
metastases across the disease course.
J Neurooncol. 2025;176:62.
PubMed
Redefining the therapeutic landscape of glioblastomas and brain metastasis
through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT).
J Neurooncol. 2025;176:66.
PubMed
Abstract available
Surgical characteristics and survival outcomes of pediatric pineal region tumors:
a cohort study in Vietnam.
J Neurooncol. 2025;176:68.
PubMed
Abstract available
Early outcomes of Gamma Knife stereotactic radiosurgery for symptomatic
intracranial meningiomas in octogenarians: technique analysis and rationale.
J Neurooncol. 2025;176:67.
PubMed
Abstract available
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2
and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment
intensification, margin reduction and epigenetic stratified outcomes with
radiation therap
J Neurooncol. 2025;176:72.
PubMed
Abstract available
Expanding morphological spectrum of pilocytic astrocytomas: insights from
integrated histopathological and multiomic profiling.
J Neurooncol. 2025;176:69.
PubMed
Abstract available
Adult ependymoma: results from the Dutch Brain Tumour Registry on primary
treatment and survival.
J Neurooncol. 2025;176:73.
PubMed
Clinical trial of feasibility for mindfulness intervention for patients with
newly diagnosed high grade glioma.
J Neurooncol. 2025;176:71.
PubMed
Abstract available
Evaluating the efficacy of a federated AI algorithm in assisting in the detection
and segmentation of brain metastases: limitations and opportunities.
J Neurooncol. 2025;176:70.
PubMed
Dual tumor control and neuroprotective efficacy of Boron Neutron Capture Therapy
in orthotopic mouse glioma model.
J Neurooncol. 2025;176:74.
PubMed
Hospital procedural volume is inversely linearly associated with complications in
endoscopic endonasal transsphenoidal resection of pituitary tumors.
J Neurosurg. 2025;143:1377-1386.
PubMed
Abstract available
Association of non-English language preference with tumor characteristics and
postoperative outcomes following pituitary neuroendocrine tumor resection:?a
retrospective review of 1143 cases.
J Neurosurg. 2025;143:1387-1397.
PubMed
Abstract available
Fiber orientation distribution for detecting skull base tumor histopathology:
technical note and retrospective 81-case series.
J Neurosurg. 2025;143:1398-1405.
PubMed
Abstract available
Examining the viability of modern endoscopic endonasal surgery as a first-line
treatment for macroprolactinomas: a multicentric study on the results and
significance of the highest preoperative prolactin level in predicting long-term
surgical outcomes
J Neurosurg. 2025;143:1364-1376.
PubMed
Abstract available
Corrigendum to: CBTRUS Statistical Report: Pediatric Brain Tumor Foundation
Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors
Diagnosed in the United States in 2017-2021.
Neuro Oncol. 2025 Oct 31:noaf238. doi: 10.1093.
PubMed
Letter: Clinical Prognostic Factors and Molecular Characteristics of Spinal Cord
Diffuse Midline Gliomas.
Neurosurgery. 2025 Nov 3. doi: 10.1227/neu.0000000000003807.
PubMed
In Reply: Clinical Prognostic Factors and Molecular Characteristics of Spinal
Cord Diffuse Midline Gliomas.
Neurosurgery. 2025 Nov 3. doi: 10.1227/neu.0000000000003806.
PubMed
cGAS-agonistic spherical nucleic acids reprogram the glioblastoma immune
microenvironment and promote antitumor immunity.
Proc Natl Acad Sci U S A. 2025;122:e2409557122.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
